AgPlus have a business to business commercial approach with the aim to develop partnerships including technology licensing, development, manufacture and supply with collaborators in a variety of applications and business sectors.

We welcome approaches from organisations that are interested in our technology to develop and enhance their competitive edge or deliver a new service to the market using biomarkers of their choice where a fully quantitative, rapid diagnostic tool is needed.

AgPlus works with partners looking to evaluate and transfer their assays to the AgPlus platform from the feasibility stage through to full assay development. We can work with development partners to deliver small scale manufacture of finished goods alongside assay development through to the technology transfer of processes where larger scale manufacture is required.

AgPlus processes and every stage of AgPlus technology development are compliant with ISO13485 standards for medical devices. This will aid development partners in the integration of the technology into their required regulatory compliance systems, for example, for CE IVDD and/or FDA approval.